Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Payables (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Payables for 15 consecutive years, with $247159.0 as the latest value for Q3 2025.

  • On a quarterly basis, Payables fell 9.73% to $247159.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $247159.0, a 9.73% decrease, with the full-year FY2024 number at $273530.0, down 13.79% from a year prior.
  • Payables was $247159.0 for Q3 2025 at Creative Medical Technology Holdings, down from $263450.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $3.3 million in Q4 2022 to a low of $247159.0 in Q3 2025.
  • A 5-year average of $669795.6 and a median of $335681.0 in 2022 define the central range for Payables.
  • Peak YoY movement for Payables: soared 328.89% in 2022, then plummeted 90.29% in 2023.
  • Creative Medical Technology Holdings' Payables stood at $761862.0 in 2021, then skyrocketed by 328.89% to $3.3 million in 2022, then tumbled by 90.29% to $317280.0 in 2023, then fell by 13.79% to $273530.0 in 2024, then decreased by 9.64% to $247159.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Payables are $247159.0 (Q3 2025), $263450.0 (Q2 2025), and $272193.0 (Q1 2025).